Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral

The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
Read the full report on Pharmtech
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Pharmtech
- Reporter
- zachary zubulake
- Published
- Saturday, 10 October 2026, 1:57 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Pharmtech with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.



